Aerie Pharmaceuticals reported $47.01M in Stock for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Alimera Sciences ALIM:US $ 1.66M 0.8M
Amarin AMRN:US $ 225.77M 42.05M
Cara Therapeutics CARA:US 3.46M 1.55M
Endo International Ordinary Shares ENDP:US $ 287.76M 3.93M
JAZZ PHA JAZZ:US $ 861.7M 123.75M
Novartis NOVN:VX SF 6880M 117M
Pacira Pharmaceuticals PCRX:US $ 100.59M 3.07M
Regeneron Pharmaceuticals REGN:US $ 2218.5M 227M
Revance Therapeutics RVNC:US $ 13.6M 2.94M
Supernus Pharmaceuticals SUPN:US $ 84.86M 3.94M
Valeant Pharmaceuticals VRX:CN $ 1382.88M 337.88M
Zoetis ZTS:US $ 2205M 148M